Chest CT scan screening for lung cancer in asbestos occupational exposure: a systematic review and meta-analysis.
Identifieur interne : 003644 ( PubMed/Curation ); précédent : 003643; suivant : 003645Chest CT scan screening for lung cancer in asbestos occupational exposure: a systematic review and meta-analysis.
Auteurs : Marie Ollier [France] ; Alain Chamoux [France] ; Geraldine Naughton [France] ; Bruno Pereira [France] ; Frédéric Dutheil [France]Source :
- Chest [ 1931-3543 ] ; 2014.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Amiante (effets indésirables), Détection précoce de cancer (), Exposition professionnelle (effets indésirables), Femelle, Humains, Mâle, Mésothéliome (imagerie diagnostique), Mésothéliome (mortalité), Mésothéliome (étiologie), Prévalence, Sujet âgé, Tabagisme (effets indésirables), Taux de survie, Tomodensitométrie, Tumeurs du poumon (imagerie diagnostique), Tumeurs du poumon (mortalité), Tumeurs du poumon (étiologie).
- MESH :
- effets indésirables : Amiante, Exposition professionnelle, Tabagisme.
- imagerie diagnostique : Mésothéliome, Tumeurs du poumon.
- mortalité : Mésothéliome, Tumeurs du poumon.
- étiologie : Mésothéliome, Tumeurs du poumon.
- Adulte d'âge moyen, Détection précoce de cancer, Femelle, Humains, Mâle, Prévalence, Sujet âgé, Taux de survie, Tomodensitométrie.
English descriptors
- KwdEn :
- Aged, Asbestos (adverse effects), Early Detection of Cancer (methods), Female, Humans, Lung Neoplasms (diagnostic imaging), Lung Neoplasms (etiology), Lung Neoplasms (mortality), Male, Mesothelioma (diagnostic imaging), Mesothelioma (etiology), Mesothelioma (mortality), Middle Aged, Occupational Exposure (adverse effects), Prevalence, Smoking (adverse effects), Survival Rate, Tomography, X-Ray Computed.
- MESH :
- chemical , adverse effects : Asbestos.
- adverse effects : Occupational Exposure, Smoking.
- diagnostic imaging : Lung Neoplasms, Mesothelioma.
- etiology : Lung Neoplasms, Mesothelioma.
- methods : Early Detection of Cancer.
- mortality : Lung Neoplasms, Mesothelioma.
- Aged, Female, Humans, Male, Middle Aged, Prevalence, Survival Rate, Tomography, X-Ray Computed.
Abstract
Lung cancer is the most frequent malignant asbestos-related pathology and remains the most fatal cancer of industrialized countries. In heavy smokers, early detection of lung cancer with chest CT scan leads to a 20% mortality reduction. However, the use of CT scan screening for early detection of lung cancer in asbestos-exposed workers requires further investigation. This study aimed to determine whether CT scan screening in asbestos-exposed workers is effective in detecting asymptomatic lung cancer using a systematic review and meta-analysis.
DOI: 10.1378/chest.13-2181
PubMed: 24480869
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003758
Links to Exploration step
pubmed:24480869Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Chest CT scan screening for lung cancer in asbestos occupational exposure: a systematic review and meta-analysis.</title><author><name sortKey="Ollier, Marie" sort="Ollier, Marie" uniqKey="Ollier M" first="Marie" last="Ollier">Marie Ollier</name><affiliation wicri:level="1"><nlm:affiliation>Department of Occupational Medicine, Clinical Research and Innovation Direction, Sport Medicine and Functional Exploration, University Hospital CHU G. Montpied, Clermont-Ferrand, France; Laboratory of Metabolic Adaptations to Exercise in Physiological and Pathological Conditions EA3533, Blaise Pascal University, Clermont-Ferrand, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Occupational Medicine, Clinical Research and Innovation Direction, Sport Medicine and Functional Exploration, University Hospital CHU G. Montpied, Clermont-Ferrand, France; Laboratory of Metabolic Adaptations to Exercise in Physiological and Pathological Conditions EA3533, Blaise Pascal University, Clermont-Ferrand</wicri:regionArea></affiliation></author><author><name sortKey="Chamoux, Alain" sort="Chamoux, Alain" uniqKey="Chamoux A" first="Alain" last="Chamoux">Alain Chamoux</name><affiliation wicri:level="1"><nlm:affiliation>Department of Occupational Medicine, Clinical Research and Innovation Direction, Sport Medicine and Functional Exploration, University Hospital CHU G. Montpied, Clermont-Ferrand, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Occupational Medicine, Clinical Research and Innovation Direction, Sport Medicine and Functional Exploration, University Hospital CHU G. Montpied, Clermont-Ferrand</wicri:regionArea></affiliation></author><author><name sortKey="Naughton, Geraldine" sort="Naughton, Geraldine" uniqKey="Naughton G" first="Geraldine" last="Naughton">Geraldine Naughton</name><affiliation wicri:level="1"><nlm:affiliation>Laboratory of Metabolic Adaptations to Exercise in Physiological and Pathological Conditions EA3533, Blaise Pascal University, Clermont-Ferrand, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratory of Metabolic Adaptations to Exercise in Physiological and Pathological Conditions EA3533, Blaise Pascal University, Clermont-Ferrand</wicri:regionArea></affiliation></author><author><name sortKey="Pereira, Bruno" sort="Pereira, Bruno" uniqKey="Pereira B" first="Bruno" last="Pereira">Bruno Pereira</name><affiliation wicri:level="1"><nlm:affiliation>Laboratory of Molecular Oncology EA 4677, Centre Jean Perrin, Clermont-Ferrand, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratory of Molecular Oncology EA 4677, Centre Jean Perrin, Clermont-Ferrand</wicri:regionArea></affiliation></author><author><name sortKey="Dutheil, Frederic" sort="Dutheil, Frederic" uniqKey="Dutheil F" first="Frédéric" last="Dutheil">Frédéric Dutheil</name><affiliation wicri:level="1"><nlm:affiliation>Department of Occupational Medicine, Clinical Research and Innovation Direction, Sport Medicine and Functional Exploration, University Hospital CHU G. Montpied, Clermont-Ferrand, France; School of Exercise Science, Australian Catholic University, Fitzroy, VIC, Australia; Laboratory of Metabolic Adaptations to Exercise in Physiological and Pathological Conditions EA3533, Blaise Pascal University, Clermont-Ferrand, France; INRA UMR 1019, UNH, CRNH Auvergne, University of Auvergne, Clermont-Ferrand, France. Electronic address: fred_dutheil@yahoo.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Occupational Medicine, Clinical Research and Innovation Direction, Sport Medicine and Functional Exploration, University Hospital CHU G. Montpied, Clermont-Ferrand, France; School of Exercise Science, Australian Catholic University, Fitzroy, VIC, Australia; Laboratory of Metabolic Adaptations to Exercise in Physiological and Pathological Conditions EA3533, Blaise Pascal University, Clermont-Ferrand, France; INRA UMR 1019, UNH, CRNH Auvergne, University of Auvergne, Clermont-Ferrand</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24480869</idno><idno type="pmid">24480869</idno><idno type="doi">10.1378/chest.13-2181</idno><idno type="wicri:Area/PubMed/Corpus">003758</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003758</idno><idno type="wicri:Area/PubMed/Curation">003644</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003644</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Chest CT scan screening for lung cancer in asbestos occupational exposure: a systematic review and meta-analysis.</title><author><name sortKey="Ollier, Marie" sort="Ollier, Marie" uniqKey="Ollier M" first="Marie" last="Ollier">Marie Ollier</name><affiliation wicri:level="1"><nlm:affiliation>Department of Occupational Medicine, Clinical Research and Innovation Direction, Sport Medicine and Functional Exploration, University Hospital CHU G. Montpied, Clermont-Ferrand, France; Laboratory of Metabolic Adaptations to Exercise in Physiological and Pathological Conditions EA3533, Blaise Pascal University, Clermont-Ferrand, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Occupational Medicine, Clinical Research and Innovation Direction, Sport Medicine and Functional Exploration, University Hospital CHU G. Montpied, Clermont-Ferrand, France; Laboratory of Metabolic Adaptations to Exercise in Physiological and Pathological Conditions EA3533, Blaise Pascal University, Clermont-Ferrand</wicri:regionArea></affiliation></author><author><name sortKey="Chamoux, Alain" sort="Chamoux, Alain" uniqKey="Chamoux A" first="Alain" last="Chamoux">Alain Chamoux</name><affiliation wicri:level="1"><nlm:affiliation>Department of Occupational Medicine, Clinical Research and Innovation Direction, Sport Medicine and Functional Exploration, University Hospital CHU G. Montpied, Clermont-Ferrand, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Occupational Medicine, Clinical Research and Innovation Direction, Sport Medicine and Functional Exploration, University Hospital CHU G. Montpied, Clermont-Ferrand</wicri:regionArea></affiliation></author><author><name sortKey="Naughton, Geraldine" sort="Naughton, Geraldine" uniqKey="Naughton G" first="Geraldine" last="Naughton">Geraldine Naughton</name><affiliation wicri:level="1"><nlm:affiliation>Laboratory of Metabolic Adaptations to Exercise in Physiological and Pathological Conditions EA3533, Blaise Pascal University, Clermont-Ferrand, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratory of Metabolic Adaptations to Exercise in Physiological and Pathological Conditions EA3533, Blaise Pascal University, Clermont-Ferrand</wicri:regionArea></affiliation></author><author><name sortKey="Pereira, Bruno" sort="Pereira, Bruno" uniqKey="Pereira B" first="Bruno" last="Pereira">Bruno Pereira</name><affiliation wicri:level="1"><nlm:affiliation>Laboratory of Molecular Oncology EA 4677, Centre Jean Perrin, Clermont-Ferrand, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratory of Molecular Oncology EA 4677, Centre Jean Perrin, Clermont-Ferrand</wicri:regionArea></affiliation></author><author><name sortKey="Dutheil, Frederic" sort="Dutheil, Frederic" uniqKey="Dutheil F" first="Frédéric" last="Dutheil">Frédéric Dutheil</name><affiliation wicri:level="1"><nlm:affiliation>Department of Occupational Medicine, Clinical Research and Innovation Direction, Sport Medicine and Functional Exploration, University Hospital CHU G. Montpied, Clermont-Ferrand, France; School of Exercise Science, Australian Catholic University, Fitzroy, VIC, Australia; Laboratory of Metabolic Adaptations to Exercise in Physiological and Pathological Conditions EA3533, Blaise Pascal University, Clermont-Ferrand, France; INRA UMR 1019, UNH, CRNH Auvergne, University of Auvergne, Clermont-Ferrand, France. Electronic address: fred_dutheil@yahoo.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Occupational Medicine, Clinical Research and Innovation Direction, Sport Medicine and Functional Exploration, University Hospital CHU G. Montpied, Clermont-Ferrand, France; School of Exercise Science, Australian Catholic University, Fitzroy, VIC, Australia; Laboratory of Metabolic Adaptations to Exercise in Physiological and Pathological Conditions EA3533, Blaise Pascal University, Clermont-Ferrand, France; INRA UMR 1019, UNH, CRNH Auvergne, University of Auvergne, Clermont-Ferrand</wicri:regionArea></affiliation></author></analytic><series><title level="j">Chest</title><idno type="eISSN">1931-3543</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Asbestos (adverse effects)</term><term>Early Detection of Cancer (methods)</term><term>Female</term><term>Humans</term><term>Lung Neoplasms (diagnostic imaging)</term><term>Lung Neoplasms (etiology)</term><term>Lung Neoplasms (mortality)</term><term>Male</term><term>Mesothelioma (diagnostic imaging)</term><term>Mesothelioma (etiology)</term><term>Mesothelioma (mortality)</term><term>Middle Aged</term><term>Occupational Exposure (adverse effects)</term><term>Prevalence</term><term>Smoking (adverse effects)</term><term>Survival Rate</term><term>Tomography, X-Ray Computed</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Amiante (effets indésirables)</term><term>Détection précoce de cancer ()</term><term>Exposition professionnelle (effets indésirables)</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Mésothéliome (imagerie diagnostique)</term><term>Mésothéliome (mortalité)</term><term>Mésothéliome (étiologie)</term><term>Prévalence</term><term>Sujet âgé</term><term>Tabagisme (effets indésirables)</term><term>Taux de survie</term><term>Tomodensitométrie</term><term>Tumeurs du poumon (imagerie diagnostique)</term><term>Tumeurs du poumon (mortalité)</term><term>Tumeurs du poumon (étiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Asbestos</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Occupational Exposure</term><term>Smoking</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Lung Neoplasms</term><term>Mesothelioma</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Amiante</term><term>Exposition professionnelle</term><term>Tabagisme</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lung Neoplasms</term><term>Mesothelioma</term></keywords><keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Mésothéliome</term><term>Tumeurs du poumon</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Early Detection of Cancer</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Lung Neoplasms</term><term>Mesothelioma</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Mésothéliome</term><term>Tumeurs du poumon</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Mésothéliome</term><term>Tumeurs du poumon</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Prevalence</term><term>Survival Rate</term><term>Tomography, X-Ray Computed</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Détection précoce de cancer</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Prévalence</term><term>Sujet âgé</term><term>Taux de survie</term><term>Tomodensitométrie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lung cancer is the most frequent malignant asbestos-related pathology and remains the most fatal cancer of industrialized countries. In heavy smokers, early detection of lung cancer with chest CT scan leads to a 20% mortality reduction. However, the use of CT scan screening for early detection of lung cancer in asbestos-exposed workers requires further investigation. This study aimed to determine whether CT scan screening in asbestos-exposed workers is effective in detecting asymptomatic lung cancer using a systematic review and meta-analysis.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24480869</PMID><DateCreated><Year>2014</Year><Month>06</Month><Day>03</Day></DateCreated><DateCompleted><Year>2014</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2017</Year><Month>05</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1931-3543</ISSN><JournalIssue CitedMedium="Internet"><Volume>145</Volume><Issue>6</Issue><PubDate><Year>2014</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Chest</Title><ISOAbbreviation>Chest</ISOAbbreviation></Journal><ArticleTitle>Chest CT scan screening for lung cancer in asbestos occupational exposure: a systematic review and meta-analysis.</ArticleTitle><Pagination><MedlinePgn>1339-1346</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0012-3692(15)34807-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1378/chest.13-2181</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Lung cancer is the most frequent malignant asbestos-related pathology and remains the most fatal cancer of industrialized countries. In heavy smokers, early detection of lung cancer with chest CT scan leads to a 20% mortality reduction. However, the use of CT scan screening for early detection of lung cancer in asbestos-exposed workers requires further investigation. This study aimed to determine whether CT scan screening in asbestos-exposed workers is effective in detecting asymptomatic lung cancer using a systematic review and meta-analysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We reviewed all cohort studies involving chest CT scan screening in former asbestos-exposed workers. The search strategy used the following keywords: "asbestos," "lung cancer," "screening," and "occupation*" or "work." Databases were PubMed, Cochrane Library, Science Direct, and Embase.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seven studies matched our inclusion criteria. Baseline screening detected 49 asymptomatic lung cancers among 5,074 asbestos-exposed workers. Of the 49 reported lung cancers, at least 18 were in the earliest stage (stage I), accessible to complete removal surgery. The prevalence of all lung cancers detected by CT scan screening in asbestos-exposed workers was 1.1% (95% CI, 0.6%-1.8%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">CT scan screening in asbestos-exposed workers is effective in detecting asymptomatic lung cancer. Detection of lung cancer in asbestos-exposed workers using CT scanning is at least equal to the prevalence in heavy smokers (1%; 95% CI, 0.09%-1.1%) and also shared a similar proportion of stage I diagnoses. Screening asbestos-exposed workers could reduce mortality in proportions previously observed among heavy smokers and, thus, should not be neglected, particularly for individuals combining both exposures.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ollier</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Occupational Medicine, Clinical Research and Innovation Direction, Sport Medicine and Functional Exploration, University Hospital CHU G. Montpied, Clermont-Ferrand, France; Laboratory of Metabolic Adaptations to Exercise in Physiological and Pathological Conditions EA3533, Blaise Pascal University, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chamoux</LastName><ForeName>Alain</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Occupational Medicine, Clinical Research and Innovation Direction, Sport Medicine and Functional Exploration, University Hospital CHU G. Montpied, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naughton</LastName><ForeName>Geraldine</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratory of Metabolic Adaptations to Exercise in Physiological and Pathological Conditions EA3533, Blaise Pascal University, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Oncology EA 4677, Centre Jean Perrin, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dutheil</LastName><ForeName>Frédéric</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Occupational Medicine, Clinical Research and Innovation Direction, Sport Medicine and Functional Exploration, University Hospital CHU G. Montpied, Clermont-Ferrand, France; School of Exercise Science, Australian Catholic University, Fitzroy, VIC, Australia; Laboratory of Metabolic Adaptations to Exercise in Physiological and Pathological Conditions EA3533, Blaise Pascal University, Clermont-Ferrand, France; INRA UMR 1019, UNH, CRNH Auvergne, University of Auvergne, Clermont-Ferrand, France. Electronic address: fred_dutheil@yahoo.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Chest</MedlineTA><NlmUniqueID>0231335</NlmUniqueID><ISSNLinking>0012-3692</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1332-21-4</RegistryNumber><NameOfSubstance UI="D001194">Asbestos</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Chest. 2014 Aug;146(2):e76-7</RefSource><PMID Version="1">25091781</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001194" MajorTopicYN="N">Asbestos</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055088" MajorTopicYN="N">Early Detection of Cancer</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008654" MajorTopicYN="N">Mesothelioma</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016273" MajorTopicYN="N">Occupational Exposure</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="Y">Tomography, X-Ray Computed</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24480869</ArticleId><ArticleId IdType="pii">S0012-3692(15)34807-8</ArticleId><ArticleId IdType="doi">10.1378/chest.13-2181</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003644 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003644 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:24480869
|texte= Chest CT scan screening for lung cancer in asbestos occupational exposure: a systematic review and meta-analysis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:24480869" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |